Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 253–288
- Headlines
- 1850
- Sources here
- 14
- Companies here
- 28
Current section
India Healthcare news
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Biocon (NSEI:BIOCON) Stock Gets Fair Value Bump On Margin Focus And Peer Valuation Cues
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Biocon's updated valuation work now points to a fair value price target of ₹429.67, compared with the earlier figure of ₹416.53. Recent research on peers …
BIOCON
main company
Sharemaestro market context
Trend signal active
52 weeks +18.7%
Insider trades: Microsoft, Meta, Pfizer among notable names
[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Key Points Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the stock, despite the potential headwinds ahead. 10 stocks we like better than Pfizer › The past few years have been …
PFIZER
main company
Sharemaestro market context
Price above Trend Line
52 weeks -8.4%